Palisade Bio Inc (NASDAQ: PALI) kicked off on Tuesday, up 42.55% from the previous trading day, before settling in for the closing price of $4.16. Over the past 52 weeks, PALI has traded in a range of $3.82-$36.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -38.82%. While this was happening, its average annual earnings per share was recorded 46.67%. With a float of $0.84 million, this company’s outstanding shares have now reached $0.85 million.
Let’s determine the extent of company efficiency that accounts for 9 employees.
Palisade Bio Inc (PALI) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Palisade Bio Inc is 1.75%, while institutional ownership is 15.52%. The most recent insider transaction that took place on Feb 06 ’24, was worth 4,692. In this transaction CEO, CFO, Director of this company bought 10,000 shares at a rate of $0.47, taking the stock ownership to the 84,649 shares. Before that another transaction happened on Jan 31 ’24, when Company’s Director bought 10,000 for $0.60, making the entire transaction worth $6,050. This insider now owns 30,000 shares in total.
Palisade Bio Inc (PALI) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.93 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.67% per share during the next fiscal year.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
Take a look at Palisade Bio Inc’s (PALI) current performance indicators. Last quarter, stock had a quick ratio of 5.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -28.25, a number that is poised to hit -3.75 in the next quarter and is forecasted to reach -17.25 in one year’s time.
Technical Analysis of Palisade Bio Inc (PALI)
Looking closely at Palisade Bio Inc (NASDAQ: PALI), its last 5-days average volume was 5.89 million, which is a jump from its year-to-date volume of 0.57 million. As of the previous 9 days, the stock’s Stochastic %D was 18.23%. Additionally, its Average True Range was 0.98.
During the past 100 days, Palisade Bio Inc’s (PALI) raw stochastic average was set at 11.39%, which indicates a significant decrease from 36.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 208.48% in the past 14 days, which was higher than the 151.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.90, while its 200-day Moving Average is $11.10. However, in the short run, Palisade Bio Inc’s stock first resistance to watch stands at $8.61. Second resistance stands at $11.28. The third major resistance level sits at $12.92. If the price goes on to break the first support level at $4.30, it is likely to go to the next support level at $2.66.
Palisade Bio Inc (NASDAQ: PALI) Key Stats
The company with the Market Capitalisation of 5.04 million has total of 852K Shares Outstanding. Its annual sales at the moment are 250 K in contrast with the sum of -12,300 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -2,970 K.
